Ayahuasca is an oral Amazonian plant brew used for psychological, spiritual and health purposes. Evidence is small and mostly psychiatric: one trial with an inactive comparison treatment supports symptom relief in depression that resisted standard treatment, and nothing addresses lifespan, aging markers or long-term disease prevention. Vomiting is the most consistently documented adverse effect. Most serious documented harms involve predisposed people and serotonin-raising medicine combinations. Relevance to longevity is unproven. (Full Review)
| Marker | Target | Why |
|---|---|---|
| Resting blood pressure | Below 120/80 mmHg | Diastolic pressure rises during ceremonies |
| Resting heart rate | 50–70 beats per minute | Captures autonomic load |
| Sodium | 138–142 mmol/L | Vomiting and diarrhea cause fluid loss |
| Potassium | 4.0–5.0 mmol/L | Vomiting and diarrhea cause electrolyte loss |
| ALT and AST (liver enzymes) | ALT below 25 U/L; AST below 25 U/L | The liver clears DMT and harmala alkaloids |
| hs-CRP | Below 1.0 mg/L | Optional inflammation marker; fell after dosing in one trial |
| CYP2D6 metabolizer status | No established target; phenotype categories are poor, intermediate, normal, ultrarapid | Harmine clearance and interaction risk |
| Pregnancy test (hCG) | Negative | Fetal harm in animal studies |
Cadence: During the session, blood pressure and heart rate every 30–60 minutes through the peak at 1.5–2 hours; then at 24–48 hours, at 1 week and at 4 weeks; every 3–6 months when the preparation is used repeatedly; electrolytes rechecked only after prolonged vomiting or diarrhea